SUMMARY In order to study arterial concentrations and splanchnic exchange of substrates and hormones in patients with chronic inflammatory bowel disease three patients with Crohn's disease and four with ulcerative colitis were studied using the hepatic venous catheter technique. Systemic turnover and regional exchange of free fatty acid were evaluated using intravenous infusion of`4C-labelled oleic acid. All measurements were made in the postabsorptive, overnight fasted state. Arterial glucose concentrations were 10% lower in the patients but net splanchnic glucose output was similar in patients and controls. Glucose precursor uptake (lactate, pyruvate, and glycerol), however, was increased two to five fold in the patients. Arterial amino acid concentrations were generally reduced but net splanchnic amino acid uptake was the same in patients and controls. Arterial concentrations of free fatty acid and oleic acid as well as systemic and fractional turnover were similar in patients and controls. The patients' splanchnic uptake of oleic acid was increased more than three fold in comparison with controls. Splanchnic release of oleic acid was also augmented in the patients. Both arterial concentrations and splanchnic production of ketone bodies were raised in the patients. The proportion of splanchnic free fatty acid uptake which could be accounted for by ketone body production was significantly greater in the patients (37±4%) than the controls (20±5%, p<0-025). Estimated hepatic blood flow was 55% greater (p<0.01) in the patients as compared with the controls (1930±150 vs 1240±70 ml/min), while splanchnic oxygen uptake was similar in the two groups. From these findings it is concluded that patients with chronic inflammatory bowel disease show (1) markedly increased hepatic blood flow, reflecting an inflammatory hyperaemia in the splanchnic region, (2) a normal net splanchnic glucose output, (3) accelerated hepatic gluconeogenesis as well as ketogenesis, probably as a consequence of the altered hormonal milieau, and (4) low concentrations of most amino acids possibly because of protein malabsorption. These findings underscore the importance of adequate protein and carbohydrate administration to this patient group.
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Most patients with active chronic inflammatory an altered availability and/or utilisation of substrates bowel disease show signs of weight loss, muscle contributes to the altered metabolic state in this wasting, and low serum albumin concentrations condition, however, is not known. Chronic inflamsuggesting a catabolic metabolic state. Mal-matory bowel disease -although not of infectious absorption of nutrients secondary to inflammatory origin -may with regard to its metabolic impact be lesions of the intestinal mucosa together with an compared with infection or starvation. In the latter increased frequency of bowel movements may conditions total glucose turnover, hepatic glucocontribute to these symptoms. The extent to which neogenesis and ketogenesis, as well as free fatty acid inflammatory bowel disease. Such information would be of particular interest not only to describe this disorder's pathophysiology but also to optimise the nutritional supply to these patients. Conse- quently, the present study was undertaken to assess arterial concentrations and splanchnic exchange of glucose and gluconeogenic precursors, as well as free fatty acid turnover, splanchnic uptake, and hepatic ketogenesis, in patients with Crohn's disease and ulcerative colitis. The studies were performed in the basal state after an overnight fast, using the hepatic venous catheter technique, and the patients' reults were compared with those of healthy subjects.
Methods

SUBJECTS
Seven patient, three with Crohn's disease and four with ulcerative colitis, were studied. Clinical data for the patients are given in 3-hydroxybutyrate and acetoacetate '3 were all determined enzymatically in whole blood. Insulin'4 and glucagon1 were determined in plasma by radioimmunoassay.
Plasma amino acid concentrations were measured by an automated ion-exchange chromatograph after protein precipitation with 30% sulphosalicylic acid. Analysis of individual free fatty acids was performed as described previously.16 Oxy en saturation was analysed spectrophotometrically 7 and haemoglobin concentration was determined by the cyanmethaemoglobin technique. Haemocrit was measured using a microcapillary centrifuge and corrected for trapped plasma. Indocyanine green dye was determined spectophotometrically at 805 nm in serum samples.
Net splanchnic exchange of substrates and oxygen was calculated as the product of the arterial-hepatic venous difference and the estimated hepatic blood flow. Splanchnic fractional extraction was calculated as (A-HV)/A where A = arterial concentrations and HV = hepatic venous concentrations. The turnover rate of oleic acid was calculated as the rate of infusion of '4C-oleic acid divided by its arterial plasma specific activity.7 The fractional turnover was obtained as the turnover rate divided by the plasma pool (arterial concentration times plasma volume). The fractional uptake (f) of oleic acid across the splanchnic vascular bed was calculated on the basis of its arterial (A) and hepatic venous (HV) radioactivity: the A-HV concentration difference in oleic acid radioactivity was divided by the corresponding arterial value (f = (A-HV)/A). The uptake of oleic acid (U, in micromoles per minute) by the splanchnic area was calculated as the product of f, the arterial plasma concentration of free oleic acid, and the splanchnic plasma flow (P). Release of oleic acid (micromoles per minute) was estimated as the difference between the uptake (U) and the net exchange of unlabelled oleic acid multiplied by P. Table 2 . The blood glucose concentration was slightly lower (10%) in the patients (p<0.05) while arterial lactate and pyruvate concentrations were similar to those of the controls. The glycerol concentration was 30% higher in the patients than in the controls (p<005). The patients' insulin concentration was approximately half of that seen in the healthy subjects (p<005) whereas the mean glucagon concentration was slightly but not significantly greater than in the controls.
Net splanchnic glucose production was similar in the patients and the healthy controls (Table 2 ). In contrast, the splanchnic uptake of lactate, pyruvate, and glycerol was two-to five-fold greater in the patients. In the case of lactate and pyruvate, an increased splanchnic fractional extraction was seen in the patients (lactate: patients 54±3%, controls 35±5%, p<005; pyruvate: patients 45±7%, controls 20±4%, p<005). Splanchnic fractional extraction for glycerol did not differ in patients (71±6%) and controls (74±5%).
AMINO ACIDS
The arterial amino acid concentrations are shown in Fig. 1 . Most amino acids were lower in the patients than in the controls. Thus, significantly reduced In spite of the low arterial concentrations, net splanchnic uptake of the individual amino acids was not reduced in the patients compared with the controls (Table 3) . Thus, a statistically significant net uptake of similar magnitude was shown in both groups for eight of the 18 amino acids studied: the largest uptake was seen for alanine and a significant uptake was noted also for threonine, serine, glycine, methionine, tyrosine, phenylalanine, and lysine. In both groups there was a significant net splanchnic output of citrulline, but the release was significantly smaller in the patient group (p<0.01). The splanchnic fractional extraction of individual amino acids was similar in the two groups.
FREE FATTY ACIDS
The arterial concentration of total plasma free fatty acids in the patient group (573±39 ,umol/l) was similar to that in the controls (669±60 ,umol/l). Likewise, no differences were seen with regard to oleic acid arterial concentration (248±18 vs 260±24 ,umol/l, NS) and total turnover rate (238±19 vs 197±19 ,umol/min, NS). Fractional turnover of oleic acid was also similar in patients (0.36±0.03) and controls (0.33±0.02). Uptake of oleic acid in the splanchnic region, however, was increased more than threefold in the patients, while oleic acid fractional extraction was similar in patients and controls (Table 4) . Splanchnic oleic acid release was more than doubled in the patient group. The arterial concentrations of ketone bodies were significantly increased in the patient (Fig. 2) . Thus, 3-hydroxybutyrate was 430±100 gmol/1 in patients as compared with 40±10 ,umol/l in controls (p<0-05). Corresponding data for acetoacetate were 220±60 and 40±10 ,umol/l (p<0.05). Splanchnic production of both ketone bodies was also increased in the patients; 3-hydroxybutyrate release was augmented sevenfold above that of the controls and acetoacetate production was increased more than fivefold ( Table 4 ). The present measurements enable one to estimate the proportion of the splanchnic free fatty acid uptake which underwent partial oxidation to ketone bodies. This proportion was found to be significantly increased in the patients (37±4%) compared with the controls (20±5%, p<0025, Fig. 2 ). Mean ± SE are indicated.
BLOOD FLOW AND OXYGEN UPTAKE
The estimated hepatic blood flow (EHBF) was increased by 55% in the patients compared with the controls (patients: 1930±150 ml/min; controls: 1240±70 ml/min, p<0.01). The A-HV oxygen difference was smaller in the patients (35.2±5.1 ml/min) than the controls (64.2±8.3 ml/min, p<005). Consequently, the net splanchnic oxygen uptake, calculated as the product of the estimated hepatic blood flow and the A--HV oxygen difference, was similar in the two groups (patients: 64-3±8.3 ml/min; controls: 55*1±2.9 ml/min; NS).
Discussion
While it is known that patients with chronic inflammatory bowel disease in the active phase have disturbances in their nutritional and metabolic status, the precise nature of these alterations has been unclear. The observations in the present study show that carbohydrate, as well as lipid and protein metabolism in these patients, is similar in many respects to the metabolic situation in early starvation and/or protein malnutrition as will be discussed below. The present patients showed an augmented uptake of gluconeogenic precursors, although net splanchnic glucose production was found not to differ from the controls. Table 5 presents balanced data for glucose precursors across the splanchnic bed, showing that the total uptake of these precursors is more than twice as great in patients than in controls. As much as 37% of the splanchnic glucose production in the patients could be accounted for by the uptake of gluconeogenic precursors, while the corresponding value for the healthy controls was no more than 17%. Splanchnic uptake of lactate, pyruvate, and glycerol was signifi- Table 5 Balance ofglucose and gluconeogenic substrates across the splanchnic vascular bed in patients with inflammatory bowel disease and healthy controls t Expressed as glucose equivalents in mmol/min. * Sum of splanchnic uptake of glycogenic amino acids for which a statistically significant uptake was found (Table 3) .
cantly augmented in the patient group, while that of alanine and other amino acids was similar to that of the controls. A major proportion of the increase in precursor uptake was because of the augmented splanchnic blood flow in the patients (+55%) but, in addition, both lactate and pyruvate showed an increase in the splanchnic fractional extraction. With regard to glycerol, the raised arterial concentration contributed to its increased splanchnic uptake. It should also be noted that as a consequence of the differences in hepatic blood flow, the splanchnic amino acid uptake in the patients was similar to that of the controls, despite markedly lowered arterial concentrations for most amino acids (Fig. 1) .
Assuming that the glucose precursors taken up are quantitatively converted to glucose, the augmented precursor uptake suggests that there is an increased rate of hepatic gluconeogenesis in patients with chronic inflammatory bowel disease. With regard to the mechanisms behind this acceleration of gluconeogenesis, it is noteworthy that the patients were slightly hypoglycaemic and showed basal insulin concentrations which were only half of those seen in the controls ( Table 2) . The latter finding, combined with normal or slightly raised glucagon concentrations (Table 2) , may contribute to a stimulation of hepatic gluconeogenesis in the patient group, in keeping with the situation in diabetes mellitus type j.6 Hormones other than insulin and glucagon may also have stimulated hepatic gluconeogenesis. Thus, an influence from cortisol, catecholamines, or growth hormone cannot be ruled out as concentrations of these hormones were not measured in the present study.
It may be speculated that a depletion of the hepatic glycogen stores may have contributed to the augmented hepatic gluconeogenesis in the patients with chronic inflammatory bowel disease. Low hepatic glycogen concentrations have been shown in patients with thyrotoxicosis 8 in which disorder there is also an increase in hepatic gluconeogenesis.19 Although the liver glycogen concentration has not been examined in patients with inflammatory bowel disease, low concentrations may be suspected in the present patients as five of the seven probably had suffered a substantial weight loss during the month preceding the study.
A striking finding in the present study was the low arterial concentrations of most plasma amino acids in the patients (Fig. 1) The normal arterial concentration and turnover rate of free fatty acids indicate that the patients with inflammatory bowel disease have a normal rate of adipose tissue lipolysis, in contrast with the accelerated lipolysis observed in brief as well as prolonged fasting.24 It is noteworthy, however, that splanchnic uptake of free fatty acids was more than three fold increased in the patients. Likewise, the splanchnic release of free fatty acids was substantially increased. Both of these processes may possibly be influenced by the augmented splanchnic blood flow in the patients. The clinical implications of the augmented free fatty acid uptake and the increased rate of gluconeogenesis are not apparent. One cannot, however, exclude the possibility that alteration in liver substrate metabolism may contribute to the hepatocellular dysfunction that is frequently seen in this patient group.25
In keeping with the increased splanchnic free fatty acid uptake the patients' arterial concentrations and splanchnic production of ketone bodies were found to be markedly raised ( Table 4 ). The rise in splanchnic ketone body output may in part be a consequence of the greater free fatty acid availability. The proportion of the hepatic free fatty acid uptake which was converted to ketone bodies, however, was also greater in the patients than in the control group (Fig. 2) , suggested an altered intrahepatic disposal of fatty acids in favour of ketone body production, similar to that seen in other hyperketonaemic states such as starvation or diabetes. 26 The In many respects the overall metabolic response to chronic inflammatory bowel disease is strikingly similar to that seen during short term (three days) starvation. In the latter condition splanchnic uptake of glucogenic precursors has increased, probabl2y reflecting an accelerated rate of gluconeogenesis, at a time when hepatic glycogen stores are depleted.36 Moreover, short term starvation, like the present disorder, is accompanied by an increased splanchnic uptake of free fatty acids and an augmented ketone body formation. The comparability of the metabolic alterations in these two conditions may in part be caused by malabsorption of nutrients in the patients. Alternatively it may reflect a common homeostatic mechanism, directed at minimising the fall in blood glucose associated with depletion of liver glycogen stores in the face of normal rate of glucose utilisation. In contrast, more prolonged starvation elicit a pronounced adaptation, involving diminished glucose utilisation and reduced gluconeogenesis, thereby allowing a marked sparing of the body protein stores. In the absence of this adaptive reaction, the patients with chronic inflammatory bowel disease are exposed to an unfavourable metabolic situation, to which is added the impact of possible protein-calorie malnutrition. From these coniderations it is apparent that the metabolic disturbance seen in this patient group may well explain the common finding of marked protein wasting and loss of body weight. The nutritional therapy in these patient should therefore be directed at providing adequate caloric supply, in particular with regard to carbohydrates as well as protein, in order to reduce gluconeogenesis, restore normal amino acid concentrations, and stimulate protein resynthesis. 
